Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Int J Radiat Oncol Biol Phys. 2024 Jun 1;119(2):507-521. doi: 10.1016/j.ijrobp.2023.10.039. Epub 2023 Dec 8.
A PENTEC (Pediatric Normal Tissue Effects in the Clinic) review was performed to estimate the dose-volume effects of radiation therapy on spine deformities and growth impairment for patients who underwent radiation therapy as children.
A systematic literature search was performed to identify published data for spine deformities and growth stunting. Data were extracted from 12 reports of children irradiated to the spine (N = 603 patients). The extracted data were analyzed to find associations between complication risks and the radiation dose (conventional fractionation throughout) as impacted by exposed volumes and age using the mixed-effects logistic regression model. When appropriate, corrections were made for radiation modality, namely orthovoltage beams.
In the regression analysis, the association between vertebral dose and scoliosis rate was highly significant (P < .001). Additionally, young age at time of radiation was highly predictive of adverse outcomes. Clinically significant scoliosis can occur with doses ≥15 Gy to vertebrae during infancy (<2 years of age). For children irradiated at 2 to 6 years of age, overall scoliosis rates of any grade were >30% with doses >20 Gy; grade 2 or higher scoliosis was correlated with doses ≥30 Gy. Children >6 years of age remain at risk for scoliosis with doses >30 Gy; however, most cases will be mild. There are limited data regarding the effect of dose gradients across the spine on degree of scoliosis. The risk of clinically meaningful height loss was minimal when irradiating small volumes of the spine up to 20 Gy (eg, flank irradiation), except in infants who are more vulnerable to lower doses. Growth stunting was more frequent when larger segments of the spine (eg, the entire spine or craniospinal irradiation) were irradiated before puberty to doses >20 Gy. The effect was modest when patients were irradiated after puberty to doses >20 Gy.
To reduce the risk of kyphoscoliosis and growth impairment, the dose to the spine should be kept to <20 Gy for children <6 years of age and to <10 to 15 Gy in infants. The number of vertebral bodies irradiated and dose gradients across the spine should also be limited when possible.
进行了一次 PENTEC(儿科正常组织在临床中的效应)综述,以评估儿童接受放射治疗后脊柱畸形和生长发育障碍的放射治疗剂量-体积效应。
进行了系统的文献检索,以确定发表的有关脊柱畸形和生长迟缓的数据。从 12 份接受脊柱照射的儿童报告(N=603 例患者)中提取数据。使用混合效应逻辑回归模型,根据暴露体积和年龄分析提取的数据,以发现并发症风险与放射剂量(常规分割)之间的关联,该剂量受放射剂量的影响。在适当的情况下,对放射方式(即正交电压束)进行了校正。
在回归分析中,椎体剂量与脊柱侧凸发生率之间存在高度显著的关联(P<.001)。此外,放射治疗时年龄较小是不良结局的高度预测因素。婴幼儿(<2 岁)时期接受 15 Gy 以上的椎体剂量即可发生明显的脊柱侧凸。对于 2 至 6 岁接受放射治疗的儿童,20 Gy 以上剂量的总体任何等级脊柱侧凸率>30%;2 级或更高级别的脊柱侧凸与剂量≥30 Gy 相关。6 岁以上儿童仍有发生 30 Gy 以上剂量脊柱侧凸的风险,但大多数为轻度。关于脊柱剂量梯度对脊柱侧凸程度的影响,数据有限。脊柱小体积照射(如侧野照射)至 20 Gy 时,导致临床意义上的身高损失的风险最小,除了婴儿对较低剂量更敏感。青春期前大段脊柱(如整个脊柱或颅脊柱照射)接受>20 Gy 剂量照射时,生长发育迟缓更为常见。青春期后接受>20 Gy 剂量照射时,这种影响较小。
为了降低脊柱侧凸和生长发育障碍的风险,<6 岁儿童的脊柱照射剂量应保持在<20 Gy,婴儿<10 至 15 Gy。应尽可能限制照射的椎体数量和脊柱剂量梯度。